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INTRODUCTION {#sec1-1}
============

Ependymomas are exceptionally rare primary intramedullary gliomas of the central nervous system.\[[@ref3],[@ref5]\] Complete surgical resection of holocervical intramedullary lesions (spanning C1-C7) is optimal.\[[@ref2]\] Here, we present two cases of gross total *en-bloc* resection of holocervical cord intramedullary ependymomas, extending from the cervicomedullary junction to the thoracic spine.

CASE DESCRIPTION {#sec1-2}
================

Patient 1 {#sec2-2_1}
---------

A 32-year-old female presented with severe progressive spastic quadriparesis attributed to a cervical cord intramedullary tumor (e.g., large cystic-enhancing expansile mass) extending from C1 to C7-T1 on MRI \[[Figure 1](#F1){ref-type="fig"}\]. She underwent a C1-T1 laminectomy for *en-bloc* tumor removal with a C2-C7 laminoplasty. Pathology deemed it a WHO grade II spinal ependymoma. Intraoperative motor-evoked potentials (MEPs) and somatosensory-evoked potentials (SSEPs) did not change. Postoperatively, her neurological examination did not deteriorate. Sixteen months later, the patient's gait ataxia and motor deficits resolved; the only residual deficit was proprioceptive loss in the right upper extremity. The 15-month postoperative MRI confirmed no evidence of residual or recurrent tumor \[[Figure 2](#F2){ref-type="fig"}\].

![Case 1. Preoperative MRI cervical spine T1-weighted with contrast (left) and T2 weighted (right). There is a large-enhancing expansile mass of the cervical spinal cord extending from the level C1-C7 measuring 9.8 × 1.2 cm. A large tumor cyst extends from end of mass at C7 inferiorly into the thoracic spine.](SNI-10-223-g001){#F1}

![Case 1. Postoperative sagittal T1-weighted with contrast (left) and T2-weighted (right) MR images of the cervical spine after laminectomy and posterior fusion. Gross total resection was achieved with no residual tumor.](SNI-10-223-g002){#F2}

Patient 2 {#sec2-2_2}
---------

A 24-year-old male also presented with a spastic quadriparesis and cervical MR-documented cystic, enhancing, expansile intramedullary mass extending from C1-C7 \[[Figure 3](#F3){ref-type="fig"}\].

![Case 2. Preoperative sagittal T1-weighted with contrast (left) and T2-weighted (right) MR images demonstrating a heterogeneous mass within the cervical cord from C1-C7. The superior portion of the mass demonstrates 1.7 × 3.6 cm cystic component.](SNI-10-223-g003){#F3}

A C1-C7 laminectomy with midline myelotomy (*en bloc* tumor removal) and C2-C7 posterior fusion was performed. MEP's remained unchanged during the surgery. Postoperatively, the patient showed no neurological worsening. Pathologically, this was deemed a WHO grade II ependymoma. One year later, the patient had 4+/5 motor strength in the upper extremities, intact motor strength in his lower extremities, and mild residual decreased sensation in the right C6-C7 dermatome. The 1-year postoperative cervical MRI showed no evidence of residual or recurrent tumor \[[Figure 4](#F4){ref-type="fig"}\].

![Case 2. Postoperative sagittal T1-weighted with contrast (left) and T2-weighted (right) MR images after laminectomy and posterior fusion. Gross total resection was achieved, albeit with marked spinal cord myelomalacia from C2-C3 through C6.](SNI-10-223-g004){#F4}

DISCUSSION {#sec1-3}
==========

Demographics {#sec2-3_1}
------------

Ependymomas tend to present more often in middle-aged adults and in the spinal cord.\[[@ref1],[@ref4]\]

Clinical presentation {#sec2-3_2}
---------------------

Patients commonly experience symptoms for over a year before their initial diagnosis.\[[@ref1]\] Common symptoms can include pain, sensory and motor deficits, gait ataxia, bladder, and bowel dysfunction.\[[@ref5]\]

MR findings {#sec2-3_3}
-----------

MR imaging of spinal ependymomas demonstrates hypo- to isointensity on T1, hyperintense on T2 studies, often with a cystic component, and heterogenous enhancement with gadolinium.\[[@ref1]\]

Surgical considerations and intraoperative monitoring {#sec2-3_4}
-----------------------------------------------------

Both cases were performed with patient in the prone position. MEP and SSEP were used throughout. Both patients had wide laminectomies performed for adequate visualization. Following central durotomies, the spinal cords of both patients were significantly expanded. Midline myelotomies were performed in the both cases under microscopic visualization and were carried superiorly and inferiorly to the poles of the tumor. Both tumors were resected *en bloc*. We have found that if a favorable plane is delineated between tumor and normal tissue, internal debulking may add unnecessary time and undue cord manipulation potentially. Frequently in our practice, there is an associated cyst at the superior and inferior poles of the tumor. Care must be taken when resecting the poles of the tumors when next to a cystic cavity, as this may cause the surgeon to lose orientation, leading to inadvertent cord manipulation. At the end of the dissection/tumor removal, the arachnoid was approximated in both patients with 6-0 proline sutures, a maneuver performed to reduce pathologic traction, prevent adhesions, and reconstitute a more anatomic central canal. The extent of bony removal increases the potential for postoperative kyphosis. The risk of deformity can be mitigated by concurrently providing rigid or semirigid internal fixation, e.g., augmenting the decompression with laminoplasty or posterior lateral mass fusion.

CONCLUSION {#sec1-4}
==========

Two patients underwent *en bloc* surgical resection of holocervical cord C1-C7 intramedullary WHO grade II ependymomas. Our patients had excellent recovery of neurological function up to and including their respective most recent follow-up visits at 28 and 12 months postoperatively.
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